Well, that would provide the base of what is necessary in terms of the definition and the approval for clinical trials, and for the research and development. But at this point the Health Canada regulatory framework does not include everything that would be in CETA as well, for instance, in terms of patent restoration, etc.
On December 10th, 2013. See this statement in context.